Clinical Trials Browser

Has results × Prostatic Neoplasms × avelumab × Clear all

NCT03217747 2026-05-05

Avelumab, Utomilumab, Anti-OX40 Antibody PF-04518600, and Radiation Therapy in Treating Patients With Advanced Malignancies

Phase 1/2 Active not recruiting

173 enrolled 28 charts

Neoplasm Metastasis, Prostatic Neoplasms

NCT03179410 2021-03-05

PICK-NEPC

Phase 2 Completed

15 enrolled 12 charts

Prostatic Neoplasms